We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XM
4401
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-2,213,900
Closed -$39.5M
BLU
4402
DELISTED
BELLUS Health Inc.
BLU
-290,375
Closed -$2.09M
HEXO
4403
DELISTED
HEXO Corp. Common Shares
HEXO
-341,613
Closed -$458K
BSFC
4404
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
-88
Closed -$11K
ONCR
4405
DELISTED
Oncorus, Inc.
ONCR
-144,000
Closed -$50K
RXDX
4406
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-243,875
Closed -$26.2M
CVT
4407
DELISTED
Cvent Holding Corp. Common Stock
CVT
-209,100
Closed -$1.75M
UNAM
4408
DELISTED
Unico American Corp
UNAM
-20,937
Closed -$23K
RUTH
4409
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-320,800
Closed -$5.27M
CS
4410
DELISTED
Credit Suisse Group
CS
-51,972,488
Closed -$46.2M
FNCH
4411
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-3,100
Closed -$37K
STSA
4412
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-164,500
Closed -$115K
APTO
4413
DELISTED
Aptose Biosciences, Inc.
APTO
-713
Closed -$205K
DBD
4414
DELISTED
Diebold Nixdorf Incorporated
DBD
-1,501,300
Closed -$1.8M
KBAL
4415
DELISTED
Kimball International
KBAL
-1,380,276
Closed -$17.1M
BLCM
4416
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-14,000
Closed -$5K
TCRR
4417
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-444,800
Closed -$667K
MNTV
4418
DELISTED
Momentive Global Inc. Common Stock
MNTV
-486,900
Closed -$4.54M
LABP
4419
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-7,920
Closed -$24K
AQUA
4420
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-179,800
Closed -$8.94M
RIDE
4421
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
-185,362
Closed -$1.84M
SGTX
4422
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-7,441
Closed -$90K
ABB
4423
DELISTED
ABB Ltd
ABB
-305,700
Closed -$10.5M
APTX
4424
DELISTED
Aptinyx Inc. Common Stock
APTX
-452,226
Closed -$56K
BIOC
4425
DELISTED
Biocept, Inc.
BIOC
-6,458
Closed -$66K

Similar funds

Renaissance Technologies's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.

  • Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
  • Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
  • Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.